Diabetic Neuropathic Foot Ulcers Global Clinical Trials Review, H1, 2014

GlobalData
April 30, 2014
79 Pages - GLDATA18037
$2,500.00

Summary

GlobalData's clinical trial report, “Diabetic Neuropathic Foot Ulcers Global Clinical Trials Review, H1, 2014" provides data on the Diabetic Neuropathic Foot Ulcers clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diabetic Neuropathic Foot Ulcers. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Diabetic Neuropathic Foot Ulcers. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Diabetic Neuropathic Foot Ulcers 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Diabetic Neuropathic Foot Ulcers to Metabolic Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Diabetic Neuropathic Foot Ulcers to Metabolic Disorders Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Diabetic Neuropathic Foot Ulcers 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials 27
Prominent Drugs 28
Latest Clinical Trials News on Diabetic Neuropathic Foot Ulcers 29
Jun 12, 2013: Derma Sciences Reports Results From DSC127 Pharmacokinetic Study 29
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Pfizer Inc. 31
Clinical Trial Overview of Pfizer Inc. 31
Olympus Biotech Corporation 32
Clinical Trial Overview of Olympus Biotech Corporation 32
HealOr Ltd. (Inactive) 33
Clinical Trial Overview of HealOr Ltd. (Inactive) 33
Regenerative Medicine Assets Limited 34
Clinical Trial Overview of Regenerative Medicine Assets Limited 34
Johnson & Johnson 35
Clinical Trial Overview of Johnson & Johnson 35
Derma Sciences, Inc. 36
Clinical Trial Overview of Derma Sciences, Inc. 36
Clinical Trial Overview of Top Institutes / Government 37
Universidade Estadual Paulista 37
Clinical Trial Overview of Universidade Estadual Paulista 37
Department of Health, UK 38
Clinical Trial Overview of Department of Health, UK 38
Kermanshah University of Medical Sciences 39
Clinical Trial Overview of Kermanshah University of Medical Sciences 39
The University of Birmingham 40
Clinical Trial Overview of The University of Birmingham 40
University of Miami 41
Clinical Trial Overview of University of Miami 41
Washington University School of Medicine 42
Clinical Trial Overview of Washington University School of Medicine 42
Five Key Clinical Profiles 43
Appendix 77
Abbreviations 77
Definitions 77
Research Methodology 78
Secondary Research 78
About GlobalData 79
Contact Us 79
Disclaimer 79
Source 79

List of Tables
Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials by Region, 2014* 6
Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 12
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13
Proportion of Diabetic Neuropathic Foot Ulcers to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 14
Diabetic Neuropathic Foot Ulcers Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Diabetic Neuropathic Foot Ulcers Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Diabetic Neuropathic Foot Ulcers to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 17
Diabetic Neuropathic Foot Ulcers Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Diabetic Neuropathic Foot Ulcers Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Terminated Clinical Trials, 2014* 23
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Diabetic Neuropathic Foot Ulcers Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 25
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 31
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Olympus Biotech Corporation, 2014* 32
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by HealOr Ltd. (Inactive), 2014* 33
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Regenerative Medicine Assets Limited, 2014* 34
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 35
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Derma Sciences, Inc., 2014* 36
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Universidade Estadual Paulista, 2014* 37
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, UK, 2014* 38
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Kermanshah University of Medical Sciences, 2014* 39
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Birmingham, 2014* 40
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2014* 41
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014* 42

List of Figures
Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 12
Proportion of Diabetic Neuropathic Foot Ulcers to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 14
Diabetic Neuropathic Foot Ulcers Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Diabetic Neuropathic Foot Ulcers Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Diabetic Neuropathic Foot Ulcers to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 17
Diabetic Neuropathic Foot Ulcers Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Diabetic Neuropathic Foot Ulcers Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Diabetic Neuropathic Foot Ulcers Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Diabetic Neuropathic Foot Ulcers Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 25
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Diabetic Neuropathic Foot Ulcers Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28
GlobalData Methodology 78

$2,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Custom Research

Need a custom report
tailored to your goals and budget? 

E-mail us your project outline
or call Client Services to speak
with your industry analyst.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax

Discount Codes

Request Discount Codes
for reports of interest to you.

info@LMRreports.com
+1 212 564 2838
+1 212 564 8133 fax